Biological Effects Induced by Specific Advanced Glycation End Products in the Reconstructed Skin Model of Aging

BioResearch Open Access

Volumn 4, Issue 1, 2015, Pages 54-64

  Pageon, Hervé ^a   Zucchi, Hélène ^a   Dai, Zhenyu ^b   Sell, David R ^b   Strauch, Christopher M ^b   Monnier, Vincent M ^b   Asselineau, Daniel ^a  

^a L ORÉAL RECHERCHE   (France)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aging; extracellular matrix; glucose; glycation; methylglyoxal; oxoaldehydes

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ALPHA6 INTEGRIN; BETA1 INTEGRIN; COLLAGEN; COLLAGEN TYPE 7; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; KALININ; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PENTOSIDINE; PROCOLLAGEN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN;

ADULT; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DERMIS; DERMOEPIDERMAL JUNCTION; EPIDERMIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

EID: 85013993838     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2014.0053     Document Type: Article

References (43)

1. Schnider SL, Kohn RR. Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen. J Clin Invest. 1981;67:1630-1635.
2. Reihsner R, Melling M, Pfeiler W, et al. Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation. Clin Biomech (Bristol, Avon). 2000;15:379-386.
3. Lohwasser C, Neureiter D, Weigle B, et al. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol. 2006;126:291-299.
4. Alikhani Z, Alikhani M, Boyd CM, et al. Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem. 2005;280:12087-12095.
5. Sejersen H, Rattan SI. Dicarbonyl-induced accelerated aging in vitro in human skin fibroblasts. Biogerontology. 2009;10:203-211.
6. Asselineau D, Prunieras M. Reconstruction of "simplified" skin: control of fabrication. Br J Dermatol. 1984;111:219-222.
7. Pageon H, Asselineau D. An in vitro approach to the chronological aging of skin by glycation of the collagen: the biological effect of glycation on the reconstructed skin model. Ann N Y Acad Sci. 2005;1043: 529-532.
8. Pageon H, Bakala H, Monnier VM, et al. Collagen glycation triggers the formation of aged skin in vitro. Eur J Dermatol. 2007;17:12-20.
9. Bernerd F, Asselineau D. UVA exposure of human skin reconstructed in vitro induces apoptosis of dermal fibroblasts: subsequent connective tissue repair and implications in photoaging. Cell Death Differ. 1998;5:792-802.
10. Pageon H, Techer MP, Asselineau D. Reconstructed skin modified by glycation of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-glycation molecules. Exp Gerontol. 2008;43:584-588.
11. Sell DR, Nagaraj RH, Grandhee SK, et al. Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes Metab Rev. 1991;7:239-251.
12. Dunn JA, McCance DR, Thorpe SR, et al. Age-dependent accumulation of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry. 1991;30:1205-1210.
13. Dammann P, Sell DR, Begall S, et al. Advanced glycation end-products as markers of aging and longevity in the long-lived Ansell'smole-rat (Fukomys anselli). J Gerontol A Biol Sci Med Sci. 2012;67:573-583.
14. Ahmed N, Thornalley PJ. Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring. Biochem Soc Trans. 2003;31: 1417-1422.
15. Sell DR, Lapolla A, Odetti P, et al. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes. 1992;41:1286-1292.
16. Asselineau D, Bernard B, Bailly C, et al. Epidermal morphogenesis and induction of the 67 kD keratin polypeptide by culture of human keratinocytes at the liquid-air interface. Exp Cell Res. 1985;159:536-539.
17. Wells-Knecht MC, Thorpe SR, Baynes JW. Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry. 1995;34:15134-15141.
18. Fu MX, Requena JR, Jenkins AJ, et al. The advanced glycation end product, N epsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem. 1996;271:9982-9986.
19. Zouboulis CC, Makrantonaki E. Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol. 2011;29:3-14.
20. Fan X, Sell DR, Zhang J, et al. Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: a comparative analysis. Free Radic Biol Med. 2010;49:847-856.
21. Mizutari K, Ono T, Ikeda K, et al. Photo-enhanced modification of human skin elastin in actinic elastosis by N epsilon-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. J Invest Dermatol. 1997;108:797-802.
22. Verzijl N, De Groot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000;275:39027-39031.
23. Alikhani M, Alikhani Z, Boyd C, et al. Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone. 2007;40:345-353.
24. Xue J, Rai V, Singer D, et al. Advanced glycation end product recognition by the receptor for AGEs. Structure. 2011;19:722-732.
25. Owen WF Jr., Hou FF, Stuart RO, et al. β2-microglobulin modified with advanced glycation ends products modulates collagen synthesis by human fibroblasts. Kidney Int. 1998;53:1365-1373.
26. Sunahori K, Yamamura M, Yamana J, et al. Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 2006;54:97-104.
27. Fujimoto E, Kobayashi T, Fujimoto N, et al. AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: epidermal-dermal interaction in acquired perforating dermatosis. J Invest Dermatol. 2010;130:404-414.
28. Nishiyama T, Amano S, Tsunenaga M, et al. The importance of laminin 5 in the dermal-epidermal basement membrane. J Dermatol Sci. 2000;25:s51-s59.
29. McMillan JR, Akiyama M, Shimizu H. Epidermal basement membrane zone components: ultrastructural distribution and molecular interactions. J Dermatol Sci. 2003;31:169-177.
30. Amano S. Possible involvement of basement membrane damage by matrix metalloproteinases and serine proteinases in skin aging process. In: Text Book of Aging Skin. Farage MA, Miller KW, Maibach HI (eds). Springer-Verlag: Berlin, 2010, pp. 121-128.
31. Dobler D, Ahmed N, Song L, et al. Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes. 2006;55:1961-1969.
32. Xia W, Hammerberg C, Li Y, et al. Expression of catalytically active matrix metalloproteinase-1 in dermal fibroblasts induces collagen fragmentation and functional alterations that resemble aged human skin. Aging Cell 2013;12:661-671.
33. Hou FF, Jiang JP, Guo JQ, et al. Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis. J Am Soc Nephrol. 2002;13:1296-1306.
34. Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochem Biophys Acta. 2010;1803:55-71.
35. Sardy M. Role of matrix metalloproteinases in skin ageing. Connect Tissue Res. 2009;50:132-138.
36. Gallucci RM, Sloan DK, Heck JM, et al. Interleukin 6 indirectly induces keratinocyte migration. J Invest Dermatol. 2004;122:764-772.
37. Weber KS, Nelson PJ, Gröne HJ, et al. Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol. 1999;19:2085-2093.
38. Trompezinski S, Berthier-Vergnes O, Denis A, et al. Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts. Exp Dermatol. 2004;13:98-105.
39. Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem. 1996;271:17779-17784.
40. Swift ME, Burns AL, Gray KL, et al. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol. 2001;117:1027-1035.
41. Ranzer MJ, Dipietro LA. Impaired wound repair and delayed angiogenesis. In: Text Book of Aging Skin. Farage MA, Miller KW, Maibach HI (eds). Springer-Verlag: Berlin, 2010, pp. 897-907.
42. Gilchrest BA. Skin aging and photoaging: an overview. J Am Acad Dermatol. 1989;21:610-613.
43. Jinnin M. Mechanisms of skin fibrosis in systemic sclerosis. J Dermatol. 2010;37:11-25.